Predictive molecular markers in the era of immunotherapy
Abstract. Recent development in anticancer therapeutics has been centered on immune checkpoint inhibitors (ICIs). Despite early success of ICIs in several cancer types, majority of cancer patients do not respond to ICI therapy. Therefore, predictive biomarkers are urgently needed to select patients...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Health/LWW
2020-09-01
|
| Series: | Journal of Pancreatology |
| Online Access: | http://journals.lww.com/10.1097/JP9.0000000000000043 |